ALTEOGEN Inc. (KOSDAQ:196170)
South Korea flag South Korea · Delayed Price · Currency is KRW
335,000
+500 (0.15%)
May 30, 2025, 12:40 PM KST

ALTEOGEN Revenue

ALTEOGEN had revenue of 83.70B KRW in the quarter ending March 31, 2025, with 139.81% growth. This brings the company's revenue in the last twelve months to 151.65B, up 25.24% year-over-year. In the year 2024, ALTEOGEN had annual revenue of 102.85B with 6.56% growth.

Revenue (ttm)
151.65B
Revenue Growth
+25.24%
P/S Ratio
117.88
Revenue / Employee
978.39M
Employees
155
Market Cap
17.88T

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024102.85B6.33B6.56%
Dec 31, 202396.52B67.72B235.08%
Dec 31, 202228.81B-9.94B-25.65%
Dec 31, 202138.75B-3.68B-8.67%
Dec 31, 202042.43B13.20B45.15%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,898.69B
Celltrion 3,662.23B
Yuhan 2,114.76B
HLB Co., Ltd. 74.64B
SK Biopharmaceuticals 578.00B
Peptron 4.30B
PharmaResearch 392.31B
LigaChem Biosciences 146.42B
Revenue Rankings